PERFUSION MEDICAL LLC — Department of Defense STTR Phase I: AFX23D-TCSO1

PERFUSION MEDICAL LLC — STTR Phase I award from Department of Defense.

Amount
$74,948
Agency
Department of Defense · Air Force
Program / Phase
STTR · Phase I
Topic
AFX23D-TCSO1
Solicitation
X23.D
NAICS
Place of performance
VA
Period
2023-05-03 → 2023-08-05

Description

Perfusion Medical is developing a new intravenous solution for the treatment of hemorrhagic shock that was developed with over $12M in U.S. Army funding at Virginia Commonwealth University. Shock is a common medical response to severe blood loss (hemorrha